Renaissance Technologies
HUMA icon

Renaissance Technologies’s Humacyte HUMA Stock Holding History

Renaissance Technologies’s Portfolio HUMA Stock Details HUMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-600,300
Closed -$2.88M – 3682
2024
Q2 		$2.88M Buy
600,300
+524,600
+693% +$2.73M ﹤0.01% 1643
2024
Q1 		$235K Sell
75,700
-19,400
-20% -$65.2K ﹤0.01% 3175
2023
Q4 		$270K Sell
95,100
-12,400
-12% -$31.8K ﹤0.01% 3025
2023
Q3 		$315K Buy
107,500
+35,900
+50% +$119K ﹤0.01% 2908
2023
Q2 		$205K Buy
71,600
+23,900
+50% +$86.2K ﹤0.01% 3295
2023
Q1 		$147K Buy
47,700
+23,900
+100% +$68K ﹤0.01% 3376
2022
Q4 		$50K Sell
23,800
-184,200
-89% -$559K ﹤0.01% 3793
2022
Q3 		$678K Buy
208,000
+196,900
+1,774% +$755K ﹤0.01% 2730
2022
Q2 		$36K Sell
11,100
-36,000
-76% -$200K ﹤0.01% 4051
2022
Q1 		$333K Buy
47,100
+32,300
+218% +$188K ﹤0.01% 3423
2021
Q4 		$107K Buy
+14,800
New +$146K ﹤0.01% 3667

Other funds holding HUMA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Voloridge Investment Management
Voloridge Investment Management Jupiter, Florida $25B AUM 28.08% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Renaissance Technologies's HUMA Position: Q3 2024 in Review

Renaissance Technologies sold out of Humacyte (HUMA) in Q3 2024, closing a stake of 600,300 shares — an estimated $2.88M sold.

Renaissance Technologies first reported a position in HUMA in Q4 2021 and held it in 11 quarters. The position peaked at $2.88M in Q2 2024. 143 funds tracked by Wall St. Rank hold HUMA as of Q3 2024.

  • Renaissance Technologies reported no remaining Humacyte position as of Q3 2024 after selling out during the quarter.
  • Renaissance Technologies sold 600,300 Humacyte shares in Q3 2024, an estimated $2.88M.
  • Renaissance Technologies first reported a position in Humacyte in Q4 2021 and held it in 11 quarters.
  • Renaissance Technologies's Humacyte position peaked at $2.88M in Q2 2024.
  • 143 funds tracked by Wall St. Rank held Humacyte as of Q3 2024.

Based on Renaissance Technologies's 13F filing for Q3 2024, filed 13 Nov 2024.